Black Stone Minerals (NYSE:BSM)
Historical Stock Chart
From May 2019 to May 2024
BSD Medical Corporation to Begin Trading on Amex as BSM
SALT LAKE CITY, June 9 /PRNewswire-FirstCall/ -- BSD Medical Corporation
(AMEX:BSM) today announced that the company will begin trading on the American
Stock Exchange (Amex) on Thursday, June 9th, using the symbol BSM. Those who
have previously traded BSD Medical's shares under the bulletin board symbol
BSDM should begin to trade using the Amex symbol BSM beginning Thursday
morning, June 9th.
"We believe that listing on the American Stock Exchange, as opposed to the
bulletin board, will help increase the visibility of BSD Medical on Wall
Street, and provide additional trading liquidity for investors," according to
Hyrum A. Mead, President of BSD Medical Corporation. "This is another
important step in our strategic efforts on behalf of the company."
This approval is contingent upon the Company being in compliance with all
applicable listing standards on the date it begins trading on the Exchange, and
may be rescinded if the Company is not in compliance with such standards.
About BSD Medical Corporation
BSD Medical develops, manufactures, markets and services systems that deliver
focused RF/microwave energy to raise temperatures within diseased sites in the
body as required by a variety of medical therapies. BSD pioneered the use of
microwave thermal therapy for the treatment of enlarged prostate symptoms
(BPH), and is responsible for much of the technology that has created a
substantial medical industry based on that therapy. BSD's primary thrust is in
the commercialization of systems used for the treatment of cancer, and in
developments to treat other diseases and medical conditions. BSD was the recent
recipient of the Frost and Sullivan "Technology of the Year Award" for cancer
therapy devices. For further information visit the BSD website at
http://www.bsdmc.com/.
Statements contained in this press release that are not historical facts are
forward-looking statements, as that item is defined in the Private Securities
Litigation Reform Act of 1995. All forward-looking statements, including all
projections and expectations of future events, such as current expectations for
the successful commercialization of developments for the treatment of cancer
and other diseases and conditions and the future price or liquidity of the
stock based on the Amex listing, are subject to risks and uncertainties, some
of which are detailed in part in the Company's filings with the Securities and
Exchange Commission.
DATASOURCE: BSD Medical Corporation
CONTACT: Hyrum A. Mead of BSD Medical Corporation, +1-801-972-5555,
fax +1-801-972-5930,
Web site: http://www.bsdmc.com/